Current News
Associate Professor Tom Scriba has co-authored a article titled "Human Immunology of Tuberculosis" in which they review the immunology of tuberculosis in the human host, focusing on cellular and humoral adaptive immunity as well as key features of innate immune responses and the underlying immunological dysfunction which associates with human TB risk factors.
SATVI has learnt with sadness that Emeritus Professor Maurice Kibel, who was associated with SATVI since its establishment, has passed away after a period of illness. Prof Kibel was an icon and pioneer in paediatrics in South Africa, establishing the Child Health Unit in the Department of Paediatrics and Child Health in 1979.
We invite applications for the position of Logistics Assistant for a 12 month contract period, to work under the supervision of the Transport and Logistic Coordinator at our Worcester Project Office. CLOSED.
We invite applications from suitably qualified Internal candidates for a 24 month contract position as Clinical Research Worker at the Worcester Field site. NOW CLOSED.
On Tuesday 23 August 2016 SATVI hosted a delegation of biomedical students from the Namibia University of Technology at the Worcester Field site.
We have a vacancy for a Quality Assurance Specialist at our Worcester Field site. NOW CLOSED
Associate Professor Mark Hatherill, Director of SATVI, will present a paper at the TB 2016 Conference taking place in Durban from 16 to 17 July 2016.
SATVI has just been awarded a grant to study the adaptive and innate immune responses associated with spontaneous reversion of QuantiFERON In Tube assay (QFT), used to determine if a person is infected with Mycobacterium tuberculosis (M.tb).
The SATVI Field Site laboratory has received verfication of their proficiency in PBMC isolation and Cryopreservation which was assessed by the Immunology Quality Assessment Contract Laboratory (IQA) at the Duke Human Vaccine Institute (HVC.
Researchers are the South African Tuberculosis Vaccine Initiative (SATVI) have acquired a Tecan Freedom EVO 150, to be used as a robotic liquid handling platform
We are inviting applications for a postdoctoral fellowship in systems immunology to conduct research on a newly funded project aimed at identifying common immune signatures and mechanisms in humans and animal models of TB. Closing Date 30 July 2016
The Laboratories of the South African Tuberculosis Vaccine Initiative have been approved to conduct tests in A5343, in support of Protocol A5343, A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid.


